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1993.-Cultured Sertoli cells of 20-day-old rats were found to 
produce and release endothelin- 1 -like immunoreactivity (ET- l- 
LI) under follicle-stimulating hormone control. The elution pro- 
file of ET-l-L1 from extracts of spent Sertoli cell culture me- 
dium corresponds to that of synthetic ET-l, suggesting a 
testicular production of authentic ET-l. In contrast, the con- 
ditioned medium from rat Leydig cells did not contain ET-I-LI. 
Immunohistochemical studies confirmed that, in 20-day-old 
rats, the positive staining was confined to some Sertoli cells, 
whereas interstitial cells were negative. In the adult rat testis 
the positivity was not limited to the tubular compartment (Ser- 
toli cells) but was also present in the interstitium. A high con- 
centration (13 pmol/mg protein) of high-affinity (dissociation 
constant = 0.6 nM) 1251-labeled ET-l binding sites was present 
in Leydig cells. These sites bind ET-l and ET-2 with l,OOO-fold 
higher affinity than ET-3, suggesting that they correspond to 
the subtype ETA of the ET receptors. Specific 1251-ET-l bind- 
ing sites are present also in Sertoli cells but are 50-fold less 
concentrated than in Leydig cells. Our results suggest an 
autocrine/paracrine role for ET-l in rat testis. 
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ENDOTHELINS (ETs) are a family of 21-amino acid pep- 
tides including four distinct isoforms (ET-l, ET-2, 
ET-3, and vasoactive intestinal contractor) that specif- 
ically interact with two populations of receptors (ETA 
and ET,; see Refs. 23,27). ETA and ETB receptors have 
been recently cloned and sequenced from bovine (2) and 
rat (24) lung, and both belong to the superfamily of G 
protein-coupled receptors. The two ET receptors differ 
in their ligand selectivities; ETB receptor binds with 
virtually equal affinity all of the ET isopeptides, whereas 
ETA does not bind ET-3. 
Because either the peptides or their receptors are dis- 
tributed widely in mammalian tissues, a large variety of 
biological actions have been attributed to ETs, including 
the control of reproductive functions (3, 10). We previ- 
ously demonstrated that ET-positive cells and ET re- 
ceptors are present in the rabbit uterus (14, 19). In 
uterus, ETs are produced by endometrium (19) and are 
biologically active on myometrial smooth muscle cells 
(14). Therefore, a role for ETs in the physiological con- 
trol of myometrial contractility was suggested (20). In 
addition to the well-characterized stimulatory effect of 
ETs on different types of smooth muscle cells (26), sev- 
eral reports indicated that ETs might also regulate ste- 
roidogenesis. Indeed, ET- 1 stimulates aldosterone secre- 
tion in bovine (5, 21), rabbit (16), rat (31), frog (6), and 
human (32) adrenal glomerulosa cells. Because in calf 
adrenal cells ET-3 (a selective ligand for ETn receptor) 
was IOO-fold less potent than ET-l in either radioligand 
binding studies or aldosterone stimulation (5), one can 
assume that ETA receptors are involved in the ET-in- 
duced stimulation of adrenocorticoid steroids. Bovine 
adrenal, indeed, expresses ETA receptor mRNA (2). 
Conversely, in porcine granulosa cells, both ET-l and 
ET-3 equally inhibited luteinizing hormone (LH)-in- 
duced adenosine 3’,5’-cyclic monophosphate (CAMP) 
formation and progesterone production, suggesting the 
presence of an ET-unselective receptor (i.e., ET& that 
negatively affects ovarian steroidogenesis (9). Because 
in the rat the ovarian (29) and adrenal (15) tissue con- 
centration of ET-l exceeds by one or two orders of mag- 
nitude the levels present in peripheral circulation a local 
production of ETs is suggested. 
The presence of elevated concentrations (100 PM) of 
immunoreactive ET-l (15), together with the relative 
abundance of preproendothelin-1 mRNA (22) in rat tes- 
tis, strongly indicates that the male gonad should be 
considered a new source of ET-l. Because several dis- 
tinct populations of cells coexist and interact within 
testis, we initiated studies to localize the testicular cells 
immunopositive for ET-l and the cells that express the 
receptor for ETs. 
MATERIALS AND METHODS 
Chemicals. 1251-labeled endothelin (ET-l) was purchased 
from Amersham (Amity, Milan, Italy). Radiochemical purity of 
the tracer was assessed by reverse-phase high-pressure liquid 
chromatography (HPLC). The labeled ligand was separated into 
aliquots in plastic tubes, sealed under nitrogen, and frozen at 
-80°C until used. ET-l, ET-2, ET-3, and sarafotoxin S6b were 
obtained from either NovaBiochem or Peninsula Laboratories 
(San Carlos, CA). The polyclonal antibody to ET-l (RAS-6901) 
was purchased from Peninsula Laboratories (San Carlos, CA); 
the monoclonal antibody to ET-l (clone TR.ET.48.5) was pur- 
chased from Affinity Bioreagents (Nashanic Station, NJ). Bo- 
vine serum albumin (BSA), bovine insulin, bacitracin, benza- 
midine, and soybean trypsin inhibitor were from Sigma (St. 
Louis, MO). Purified human chorionic gonadotropin (hCG, 
13,000 IU/mg) was a gift of Y.-Y. Tsong (the Population Coun- 
cil, NY). 3,4,3’,4’,Tetraaminodiphenyl hydrochloride (Diami- 
nobenzidine) was obtained from BDH Chemical. Universal im- 
munoperoxidase staining kits were obtained from Cambridge 
Research Laboratories. Murine epidermal growth factor (EGF) 
was purchased from Biomedical Technologies (Cambridge, 
MA). Ovine follicle-stimulating hormone [FSH; National Insti- 
tutes of Health (NIH) FSH S17; FSH activity: biological po- 
tency = 20 x NIH FSH Sl U/mg] was a gift from the National 
Hormone and Pituitary Program, National Institute of Diabe- 
tes and Digestive and Kidney Diseaes, NIH. Forskolin, human 
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Fig. 1. Reverse-phase high-pressure liquid chromatography (HPLC) 
profile of extract from conditioned medium of Sertoli cells. Concentra- 
tions of endothelin-l-like immunoreactivity (ET-l-LI) in each l-ml 
fraction are shown by open circles. Retention times of standard ET-l, 
ET-2, and ET-3 are indicated by arrows. Peak of ET-l-L1 emerged at 
position corresponding to that of authentic ET-l. 
transferrin, and 17P-estradiol (17PE,) were obtained from Cal- 
biochem-Behring (La Jolla, CA). Collagenase-dispase was pur- 
chased from Boeringher Mannheim (Indianapolis, IN). Pow- 
dered F-12/Dulbecco’s modified Eagle’s (DME) medium was 
obtained from Irvine Scientific (Irvine, CA). Serum-free (SF) 
medium was prepared from reconstituted F-12-DME medium 
(F-12-DME) containing 1.2 g/l sodium bicarbonate, 15 mM 
HEPES (Research Organics, Cleveland, OH), and 20 mg/l gen- 
tamycin (GIBCO, Grand Island, NY). Low insulin-containing 
medium contained (in pg/ml) 2.5 insulin, 1 human transferrin, 
and 5 bacitracin. 
Sertoli and Leydig cell cultures. Sprague-Dawley rats (20 days 
old) were killed after asphyxiation in a C02-precharged cham- 
ber. Testes were removed and placed in sterile F-12-DME. SF 
cultures of Sertoli and Leydig cells were prepared from decap- 
sulated testes as reported previously (11, 17). 
For membrane preparation from cultured cells, the Sertoli 
cell-enriched (SCE) suspension was plated in IOO-mm dishes in 
SF medium supplemented with bovine insulin (10 pg/ml), hu- 
man transferrin (1 pg/ml), and bacitracin (5 pg/ml) and allowed 
to attach. After 4 days, the SF medium was replaced with char- 
coal-stripped serum (5% horse serum and 2.5% newborn calf 
serum) with or without 20 nM 17PE2 to evaluate the effects of 
estrogens on 1251-ET-1 binding, as previously shown in rabbit 
myometrium (14). Particulate membranes were prepared after 
48 h of treatment. Leydig cell-enriched (LCE) preparations 
were cultured in loo-mm dishes in SF medium supplemented 
30 r 0 24h n 48h 
with bovine insulin (10 pg/ml), human transferrin (1 pg/ml), 
bacitracin (5 pg/ml), and hCG (100 rig/ml). Membranes were 
prepared on day 7 of culture. 
For the determination of ET secretion, SCE preparations 
were plated in loo-mm dishes in low-insulin-containing me- 
dium. The medium was removed after 24 h and replaced with 
fresh medium containing the following treatments: FSH (50 and 
300 rig/ml), forskolin (1 and 10 PM), EGF (2.5 rig/ml), or vehicle 
[phosphate-buffered saline (PBS)]. The conditioned medium 
was removed after 24 or 48 h and saved at -20°C. LCE prepa- 
rations were plated as before, but the following treatments were 
added after 30 min: hCG (100 rig/ml), prolactin (PRL; 100 
rig/ml), EGF (2.5 rig/ml), or vehicle (PBS). Media were col- 
lected after 24, 65, or 96 h and stored at -2OOC. 
Membrane preparation. At the time of membrane preparation 
the cells were washed carefully with ice-cold PBS, harvested by 
scraping in PBS, and centrifuged at low speed. Membranes were 
prepared as described previously (13). Briefly, cells were homog- 
enized in buffer 1 [ 10 mM tris(hydroxymethyl)aminomethane 
(Tris) l HCl, pH 7.4, 1.5 mM EDTA, 0.5 mM dithiothreitol, 1 
mM benzamidine, 0.01% bacitracin, 0.002% soybean trypsin 
inhibitor], and the homogenate was centrifuged at 1,000 g for 10 
min at 4°C. The supernatant containing the crude membrane 
fraction was then ultracentrifuged at 160,000 g for 30 min at 
4°C. The resulting pellets were washed one time in buffer 2 (50 
mM Tris-maleate, pH 7.6, 10 mM MgS04, 1 mM benzamidine, 
0.01% bacitracin, 0.002% soybean trypsin inhibitor) and cen- 
trifuged again at 160,000 g for 30 min at 4°C. The final pellets 
were then resuspended in buffer 2 and divided into small ali- 
quots. The membrane preparations were frozen in solid CO, and 
stored at -80°C until assayed. Protein concentrations were de- 
termined using the Pierce protein assay reagent (Pierce Chem- 
ical, Rockford, IL), according to the “standard assay procedure” 
recommended by the manufacturer. 
Binding studies. Binding studies were carried out as described 
previously (14). Aliquots of membranes (0.075 mg/ml) were in- 
cubated for 120 min at 4°C in buffer 2 in the presence of 0.01% 
BSA, with increasing concentrations (lo-70 PM) of 1251-ET-l, 
with or without increasing concentrations of unlabeled ligands. 
All measurements were obtained in triplicate. After incubation, 
membranes were filtered through Whatman GF/B filters (Clif- 
ton, NJ), presoaked in ice-cold 50 mM Tris, pH 7.4, in 0.1% 
BSA, using the Brandel M-48R 48-well cell harvester (Gaith- 
ersburg, MD). Filters were washed two times with 3 ml ice-cold 
50 mM Tris, pH 7.4. Radioactivity retained by filters was mea- 
sured in a gamma counter at 70% efficiency. The binding data 
were evaluated quantitatively with non-linear least-square 
curve fittings using the computer programs LIGAND (18) and 
ALLFIT (7). 
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Fig. 2. Effects of follicle-stimulating hormone 
(FSH; 50-300 rig/ml), forskolin (Forsk; l-10 PM), 
and epidermal growth factor (EGF; 2.5 rig/ml) on 
ET-l-L1 secretion from rat Sertoli cells in primary 
culture. Sertoli cells were incubated for 24 or 48 h 
with hormones. 
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Fig. 3. Photomicrographs of cross sections of seminiferous tu- 
bules from 20-day-old rats (x200 magnification). A: section 
immunostained with monoclonal antiserum to ET-l. Some 
Sertoli cells were positively stained (thin arrows), whereas 
interstitial cells were negative (thick arrows). Similar results 
were obtained using polyclonal antibody to ET-1 (not shown). 
B: control section (hematoxvlin counterstained): immunoab- 
sorption of antiserum with synthetic ET-l (100 nM) has com- 
pletely prevented staining. 
ET-l radioimmunoassay. ET-1 radioimmunoassay (RIA) was 
performed essentially as previously reported (19). ET-l was 
extracted from conditioned media (1.5-2.0 ml) using Sep-Pak 
Cl8 cartridges (Waters, Millipore, MA) previously activated 
with acetonitrile, trifluoroacetic acid (TFA), and water (60~0. 
1:39.9 vol/vol/vol) and washed with water TFA (99.9:O.l vol/ 
vol). Immunoreactive ET-1 was eluted with acetonitrile, TFA, 
and water, evaporated to dryness by a centrifugal concentrator 
(Univapo 150 H; Uni Equipe, Martinsned, Germany), and re- 
constituted in assay buffer for RIA or HPLC analysis. 
The assay buffer for ET-l RIA was a 100 mM PBS, pH 7.4 
(0.1% Triton X-100, 0.1% BSA, and 0.01% NaN,). Samples or 
standards (0.1 ml) were preincubated with rabbit anti-ET-l 
antiserum (0.1 ml, final dilution 1:60,000) at 4°C overnight and 
further incubated with lz51-ET-1 (0.1 ml, 10 PM) in the same 
condition. Bound-to-free separation was performed by the sec- 
ond antibody technique. The sensitivity of the assay was 0.4 
pgltube. 
HPLC. Reverse-phase HPLC was performed using a Waters 
Resolve C1s 5-pm column (150 x 3.9 mm). ETs were eluted with 
a linear gradient of acetonitrile (from 30 to 90% in 0.1% TFA) 
for 40 min, with a flow rate of 1 ml/min. Fractions (1 ml) were 
collected, evaporated to dryness, reconstituted in assay buffer, 
and subjected to RIA. 
Immunohistochemistry. Immunohistochemical studies were 
performed as described previously (14). Briefly, testes derived 
from 20-day-old and adult Sprague-Dawley rats were fixed in 
Bouin’s solution for 4 h, embedded in paraffin, and sectioned. 
At the time of the experiment the sections, after being depar- 
affmized and rehydrated, were incubated for 24 h with the two 
ET-l antiserums (working dilutions: 1:1,500 and 1:lOO for the 
polyclonal and monoclonal antiserum, respectively). Sections 
were rinsed in PBS and then incubated with the specific im- 
munoglobulin G peroxidase conjugates for 30 min. The dilutions 
of the second antibodies were l:l,OOO and 1:500 for sections 
incubated with the polyclonal or the monoclonal antiserum, 
respectively. The sections were rinsed again in PBS and finally 
washed in 50 mM Tris. Demonstration of peroxidase activity 
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Fig. 4. Sections from adult rat testis immunostained with 
polyclonal antibody against ET-l . A: strong staining can 
be detected in cytoplasm of some Sertoli cells. Weak 
staining is present also in interstitium (X200 magnifica- 
tion). B: higher magnification of A. Note intense cyto- 
plasmic staining of Sertoli cells (X750 magnification). C: 
control section incubated with polyclonal antiserum pre- 
incubated with ET-l (100 nM); no staining was seen 
(hematoxylin counterstained, ~200 magnification). 
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Fig. 5. Seminiferous tubules from adult rat 
testis immunostained with monoclonal 
antibody against ET-l. A: Sertoli cells 
with stained cytoplasm are seen in tubules 
(thin arrows). Minority of interstitial cells 
shows positive staining for ET-1 (thick ar- 
rows; ~200 magnification). B: hematoxy- 
lin-counterstained higher magnification of 
A (x750 magnification) showing positive 
staining in cytoplasm of Sertoli cells (thin 
arrows) and in 1 interstitial cell (thick ar- 
row). Arrowheads indicate unstained sper- 
matocytes. 
and controls for specificity of the antisera were carried out as 
previously described (14). 
The slides were evaluated and photographed using a Nikon 
MICROPHOT-FX microscope (Nikon, Kogaku, Tokyo, 
Japan). 
RESULTS 
RIA and HPLC &.&es. ET-1-like-immunoreactivity 
(ET-l-LI) was found in the extracts from Sertoli cell- but 
not from Leydig cell-conditioned media. The dilution 
curves of the conditioned medium from Sertoli cells was 
parallel to that of standard ET-l, suggesting that the 
ET-like material present in the extracts is immunologi- 
cally indistinguishable from authentic ET-l (data not 
shown). An elution profile of Sertoli cell media extract on 
reverse-phase HPLC is shown in Fig. 1. A major compo- 
nent of ET immunoreactivity was eluted in the position 
corresponding to authentic ET- 1. 
Either FSH or forskolin decreased the secretion of 
ET-l-L1 in a dose-dependent manner. After the addition 
of the highest (2 days) dose of FSH (300 rig/ml) or for- 
skolin (10 PM) the secretion of ET-l-L1 was reduced lo- 
and 5-fold, respectively. Conversely, treatment with 
EGF (2.5 rig/ml) did not affect ET-l-L1 release (Fig. 2). 
ET-l-L1 was undetectable in extracts from Leydig cell 
media either in the basal condition or after different 
hormonal treatment (hCG, EGF, PRL) for various times 
(24, 65, 96 h). 
Immunohistochemical studies. In 20-day-old rat testis, 
immunostaining for ET-l was exclusively found in Ser- 
toli cells using either the monoclonal (Fig. 3A) or the 
LEVDIG cells 
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Fig. 6. Equilibrium binding of 1251-labeled ET- 1 to Leydig cells (open 
circles) or Sertoli cells (filled circles). Ordinate: B/F, bound-to-free ra- 
tio; abscissa: concentration of bound ligand (pmol/mg protein). Note 
dramatic difference in concentration of ET-l binding sites in 2 popu- 
lations of testicular cells. 
polyclonal antiserum (data not shown). Similar results 
were also obtained in the adult rat testis using both an- 
tibodies (Fig. 4, A and B and Fig. 5, A and B). However, 
in the adult testis the staining was not confined to the 
seminiferous tubules but was also present in the intersti- 
tium (Fig. 4A and Fig. 5, A and B). In the labeled cells, 
staining was observed in the cytoplasm. When the anti- 
serum was previously absorbed with synthetic ET-l (100 
nM), no staining could be detected in both tubular and 
interstitial compartments (Figs. 3B and 4C). 
Binding studies. Binding of 1251-ET-1 to membranes 
from Leydig cells reached apparent equilibrium within 
120 min at 4°C (data not shown). Hence, subsequent 
binding studies were carried out at this time point. In 
Leydig cells, Scatchard analysis of equilibrium binding 
curves for ET-l revealed a single class of high-affinity 
high-capacity binding sites [dissociation constant (&) = 
0.63 t 0.13 nM; binding capacity = 13 t 5 pmol/mg 
protein; mean t SE of 3 separate experiments from a 
single membrane preparation]. A representative Scat- 
chard plot is shown in Fig. 6. Also shown in Fig. 6 is a 





these cells, ET-l still binds with high affinity (& = 0.33 
nM). However, the density of ET-l receptors was 50-fold 
lower than in Leydig cells (0.2 pmol/mg protein). The 
subacute treatment (48 h) of Sertoli cells with 20 nM 
17PE2 did not affect either the receptor density or the 
affinity constant of ET-l (& = 0.28 nM; maximal bind- 
ing = 0.25 pmol/mg protein). Figure 7 shows a family of 
competition curves for 1251-ET-1 binding in Leydig cells. 
Among the different ET isopeptides tested, ET-l and 
ET-2 displaced with the highest affinity 1251-ET-1 bind- 
ing, whereas ET-3 was l,OOO-fold less potent than ET-l, 
suggesting the presence of ETA receptors. 
DISCUSSION 
Testicular activity is mainly regulated by the pituitary 
hormones LH and FSH. However, there is now a consid- 
erable body of physiological evidence suggesting that Ley- 
dig cell function is also modulated by factors derived from 
the seminiferous tubules (28, 30). This is the first dem- 
onstration that Sertoli cells from immature rats contain 
and release, under FSH and CAMP control, an ET-related 
peptide that is apparently indistinguishable from authen- 
tic ET-l. We suggest that ET-l represents a new para- 
crine factor produced by Sertoli cells and involved in the 
regulation of interstitial Leydig cell activity. Indeed, re- 
ceptors for ET-l are present in high density in Leydig 
cells. The pharmacological characterization of 1251-ET-1 
binding to Leydig cells indicates that ETA receptors are 
predominantly present in these cells. The concentration 
of ETA receptors in Leydig cells is lo-fold higher than in 
aorta and comparable to the density found in the uterus 
(14,12), suggesting a role in testicular physiology. Recent 
reports from other groups indicate that ET-l might in- 
deed affect Leydig cell activity, increasing basal and 
hCG-induced steroidogenesis (4, 8). These findings, to- 
gether with the evidence of ETA mRNA in primate testis 
(1), strongly suggest a positive role for ET-l in the regu- 
lation of testicular steroidogenesis, as previously reported 
for adrenal steroidogenesis (5, 6, 16, 21, 31, 32). 
The immunohistochemical results obtained in rat tes- 
tis using a polyclonal or a monoclonal antiserum against 
Fig. 7. Displacement of specific 1251-ET-1 binding to 
Leydig membranes by ET isopeptides. Membranes 
(0.075 mg/ml) were incubated for 120 min at 4°C 
with 50 pM 1251-ET-1 in presence or absence of in- 
creasing concentrations of the following peptides: 
ET-l, ET-2, ET-3, and sarafotoxin S6b (SRTX). 
B/T, bound-to-total ratio. 
-10 -8 -6 
LOG [ LIGAND] 
ET-l IN TESTIS E273 
ET-l are relatively consistent. In the immature rat testis, 
immunoreactive ET-1 is limited to Sertoli cells. This is in 
perfect agreement with results derived from testicular 
cells in culture. In adult rat testis, the immunostaining 
pattern of ET-1 in the seminiferous tubule is similar to 
immature rats, and positive staining was also present in 
the interstitium, suggesting an age-dependent change in 
the immunohistochemical localization of ET-l. We also 
found that either in adult or in immature rat testis not all 
of the Sertoli cells are labeled in adjacent tubules. This 
might indicate a stage-specific production of ET-1 within 
the seminiferous tubules. 
1251-ET-l binding sites are present also in Sertoli cells, 
although the density of sites in these cells is dramatically 
lower (i.e., 5O-fold) than in Leydig cells. Furthermore, the 
ET-l receptor concentration in Sertoli cells is not appar- 
ently affected by estradiol, as previously reported in the 
rabbit female genital tract (12, 14). Because it has been 
shown that, in rat Sertoli cells, ET-1 increases intracell- 
ular calcium and modulates both the CAMP and estradiol 
response to FSH (25), an autocrine role for ET-l within 
the seminiferous tubule should also be considered. 
In conclusion, we report that Sertoli cells from imma- 
ture rats produce and release ET-l, whereas receptors for 
this peptide are present in both Leydig cells and Sertoli 
cells. Hence, ET-l represents a new factor probably in- 
volved in the local control mechanism for the exchange of 
information within the testis. 
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